Astrazeneca AZN
NYSE AZN
$163.66 +3.49 (+2.18%)
As of: Sep 14, 2026 · 3:07 PM EDT

Astrazeneca (AZN) Cash & Equivalents Growth (5y) (2014 - 2026)

Analysis

Astrazeneca (AZN) Cash & Equivalents Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Asml Holding 618.04 Bn 602.06 Bn 5.90 Bn
2 Hsbc Holdings 362.64 Bn 362.64 Bn -
3 General Electric 329.87 Bn 320.52 Bn 6.95 Bn
4 Astrazeneca 253.67 Bn 248.39 Bn 12.86 Bn
5 Citigroup 228.64 Bn -2,073.66 Bn 24.75 Bn
6 Bhp 216.08 Bn 197.54 Bn -
7 Rio Tinto 203.71 Bn 199.33 Bn -
8 Diageo 197.09 Bn 195.06 Bn -
9 Unilever 139.34 Bn 132.31 Bn -
10 Hdfc Bank 117.87 Bn 80.72 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -20.66%
Mar 31, 2026 -0.20%
Dec 31, 2025 -6.12%
Sep 30, 2025 0.18%
Jun 30, 2025 4.47%
Mar 31, 2025 8.91%
Dec 31, 2024 0.44%
Sep 30, 2024 3.87%
Jun 30, 2024 4.96%
Mar 31, 2024 13.65%
Dec 31, 2023 33.73%
Sep 30, 2023 7.33%
Jun 30, 2023 13.72%
Mar 31, 2023 15.71%
Dec 31, 2022 13.15%
Sep 30, 2022 2.01%
Jun 30, 2022 -1.67%
Mar 31, 2022 12.99%
Dec 31, 2021 4.75%
Sep 30, 2021 17.99%